BMS 527 (Sprycel 20 mg)
Generic Name: dasatinib
Pill imprint BMS 527 has been identified as Sprycel 20 mg.
Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 20 mg is not subject to the Controlled Substances Act.
See also related documents.
- Generic Name:
- 20 mg
- Prescription only
More about Sprycel (dasatinib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.